Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase II study of bortezomib in Waldenstrom's Macroglobulinemia: Results of WMCTG trial 03-248. 47th Annual Meeting of the American-Society-of-Hematology Treon, S., Hunter, Z. R., Matous, J., Badros, A., Joyce, R. M., Mannion, B., Advani, R., Cook, D., Songer, J., Hill, J., Kaden, B. R., Sharon, D., Steiss, R., Branagan, A. R., Patterson, C. J. AMER SOC HEMATOLOGY. 2005: 147A–147A
View details for Web of Science ID 000233426000491